Technomark Life Sciences is looking for opportunities to co-develop products with biotechnology and life-science companies.
Technomark, with headquarters in Research Triangle Park, plans to work with partner companies on a risk-sharing basis to advance product development.
"We are very excited to be in a position now to partner with biotechnology and other life science companies on their preclinical or clinical product development," said Allen Hakimi, managing director of Technomark.
The company will use product development services as capital in order to share and reduce the cost of the development program. In exchange, Technomark will receive equity, downstream royalties, and/or regional rights in emerging countries such as India, China and South Africa.
Technomark hopes to identify at least five development programs in which it can participate in 2009. For more information, please contact Britt Akermann, director of operations at +44 (0) 770 460 6340.
Technomark Life Sciences is a 20-year-old, specialty life science firm with a world-wide reputation for excellence. With offices in Research Triangle Park (NC-USA), London (UK), Mumbai (India), and Nanjing (China), the company specializes in product development, regional licensing and partnering, and CRO/CMO corporate growth. For more information please visit
www.technomarkls.com.